Paul Burns
Partner
New York

Paul Burns
Partner
New York
Contact details
Paul advises on mergers and acquisitions, joint ventures, strategic alliances and general corporate matters, and represents clients before the SEC, NYSE and Nasdaq.
Qualifications
Academic
J.D., Yale Law School, 1995
B.A., Princeton University, magna cum laude, 1991
Experience highlights
Apax Partners and its portfolio company Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the central nervous system, on the acquisition of the assets and rights related to prescription brand Buccolam® from Takeda Pharmaceutical Company
Advising a global healthcare company on three separate divestures from their Consumer Healthcare business as part of a GBP1bn divestiture program.
IHS Towers, one of the largest independent owners, operators and developers of shared telecommunications infrastructure in the world by tower count, on its agreement to purchase Brazilian-headquartered infrastructure solutions provider Cell Site Solutions from affiliates of Goldman Sachs and Centaurus Capital LP.
EQT in its acquisition of Igenomix, a global leader in women’s health and reproductive genetic services for IVF (In Vitro Fertilization) clinics, with 15 laboratories across 13 countries.
Related articles

News: 26 August 2022
Four Allen & Overy practice groups highly recommended by Latin Lawyer 250
Allen & Overy (A&O) announced today its antitrust & competition, banking & finance, corporate & M&A, and project finance & infrastructure practices were ranked as 'highly recommended' in the 24th…
Blog Post: 18 December 2020
Publications: 16 December 2020
Publications: 15 December 2020

Qualifications
Academic
J.D., Yale Law School, 1995
B.A., Princeton University, magna cum laude, 1991